17h
Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma
Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in ...
PARIS, FRANCE, 09 March 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik (tazemetostat) in all indications from all Ipsen markets. Ipsen's decision ...
Nearly thirty leading global solar and energy media outlets recently visited JA Solar's Yangzhou manufacturing and testing facilities for an exclusive ...
The arterial vasculature is the second most frequently calcified structure in the human body after the skeleton. Calcification of the aorta and aortic valves occurs in most individuals in westernized ...
Nova Minerals Ltd. ) is pleased to announce assay results from its 2025 surface sampling program in the RPM regional and ridgeline area of the Company's flagship Estelle Gold and Critical Minerals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results